adenocarcinoma

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Lung Tumors, NSCLC, Lung Diseases Trial in Worldwide (CK-101)

Completed
  • Lung Neoplasms
  • +3 more
  • Sarasota, Florida
  • +19 more
Jul 25, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)

Terminated
  • Non-Small Cell Lung Cancer
  • +3 more
  • Tucson, Arizona
  • +34 more
Oct 11, 2021

Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)

Terminated
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Saint Louis, Missouri
  • +1 more
Jun 15, 2021

Breast Cancer, Pancreatic Cancer, Colorectal Cancer Trial in Oklahoma City, Nashville (MORAb-066)

Completed
  • Breast Cancer
  • +5 more
  • Oklahoma City, Oklahoma
  • +1 more
Apr 14, 2020

Adenocarcinoma Trial in United States (Bevacizumab, Capecitabine, Cisplatin)

Completed
  • Adenocarcinoma
  • Beverly Hills, California
  • +12 more
May 16, 2017

Adenocarcinoma, Non-Small-Cell Lung Carcinoma, Lung Tumors Trial in Canada, United States (Motexafin Gadolinium)

Completed
  • Adenocarcinoma
  • +2 more
  • Motexafin Gadolinium
  • Fountain Valley, California
  • +15 more
Aug 19, 2008